S&P 500   2,990.40 (-0.25%)
DOW   26,830.66 (-0.72%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
BABA   170.36 (-3.67%)
GE   8.99 (-0.55%)
TSLA   256.90 (-1.94%)
AMD   30.81 (-1.06%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
NFLX   275.28 (-6.16%)
GILD   64.23 (-1.53%)
DIS   131.27 (-0.83%)
S&P 500   2,990.40 (-0.25%)
DOW   26,830.66 (-0.72%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
MU   43.47 (-4.46%)
BABA   170.36 (-3.67%)
GE   8.99 (-0.55%)
TSLA   256.90 (-1.94%)
AMD   30.81 (-1.06%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
NFLX   275.28 (-6.16%)
GILD   64.23 (-1.53%)
DIS   131.27 (-0.83%)
Log in

Plethora Solutions Stock Price, News & Analysis (LON:PLE)

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume2.13 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Plethora Solutions Holdings PLC is focused on the development and commercialization of its principal pharmaceutical product, PSD502. The Company is engaged in the development and commercialization of pharmaceutical treatments for premature ejaculation in the area of men's sexual health. The Company's segments are Plethora Development and Corporate/Unallocated.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+44-20-30775400

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive PLE News and Ratings via Email

Sign-up to receive the latest news and ratings for PLE and its competitors with MarketBeat's FREE daily newsletter.


Plethora Solutions (LON:PLE) Frequently Asked Questions

What is Plethora Solutions' stock symbol?

Plethora Solutions trades on the London Stock Exchange (LON) under the ticker symbol "PLE."

Has Plethora Solutions been receiving favorable news coverage?

News headlines about PLE stock have trended neutral this week, InfoTrie reports. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Plethora Solutions earned a coverage optimism score of 0.2 on InfoTrie's scale. They also assigned news articles about the specialty pharmaceutical company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Plethora Solutions.

What other stocks do shareholders of Plethora Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Plethora Solutions investors own include Hurricane Energy (HUR), Sirius Minerals (SXX), Ithaca Energy (IAE), Lekoil (LEK), Ixia (XXIA), Greene King (GNK), Premaitha Health (NIPT), Carrizo Oil & Gas (CRZO), Hurricane Energy (HRCXF) and Ithaca Energy (IACAF).

How do I buy shares of Plethora Solutions?

Shares of PLE and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Plethora Solutions' official website?

The official website for Plethora Solutions is http://www.plethorasolutions.co.uk/.

How can I contact Plethora Solutions?

Plethora Solutions' mailing address is Hampden House Monument Business Park, Warpsgrove Lane, OXFORD, OX44 7RW, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-20-30775400.


MarketBeat Community Rating for Plethora Solutions (LON PLE)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  88 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  164
MarketBeat's community ratings are surveys of what our community members think about Plethora Solutions and other stocks. Vote "Outperform" if you believe PLE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PLE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: Most Volatile Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel